Fneish, Firas http://orcid.org/0000-0001-8279-8463
Ellenberger, David http://orcid.org/0000-0002-2274-5025
Frahm, Niklas http://orcid.org/0000-0002-4655-774X
Stahmann, Alexander http://orcid.org/0000-0001-5308-105X
Fortwengel, Gerhard
Schaarschmidt, Frank http://orcid.org/0000-0002-6599-3803
Funding for this research was provided by:
Gottfried Wilhelm Leibniz Universität Hannover
Article History
Received: 2 January 2023
Accepted: 8 June 2023
First Online: 14 July 2023
Declarations
:
: FF is an employee of Leibniz University Hannover and the German MS Registry. DE had no personal financial interests to disclose other than being an employee of the German MS Registry. NF is an employee of the MSFP. Moreover, he received travel funds for research meetings from Novartis. AS has no personal financial interests to disclose, other than being the leader of the German MS Registry, which receives (project) funding from a range of public and corporate sponsors, recently including G-BA, The German MS Trust, German MS Society, The German Retirement Insurance, Biogen, Celgene (Bristol Myers Squibb), Merck, Novartis, Roche, Sanofi and Viatris. GF has nothing to disclose. FS has nothing to disclose.